, Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2012.

T. Hannedouche, S. Briançon, M. Lassalle, B. Stengel, and R. Registre, ESRD incidence rates. REIN-Rapport annuel, 2012.

C. J. Chung, C. Y. Huang, H. B. Tsai, C. H. Muo, M. C. Chung et al., Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in Taiwan, PLOS one, vol.7, issue.9, pp.1-7, 2012.

G. Wong, A. Hayen, J. R. Chapman, A. C. Webster, A. C. Wang et al., J Am Soc Nephrol, vol.20, pp.1341-1350, 2009.

G. Wong, S. Zoungas, S. Lo, J. Chalmers, A. Cass et al., The risk of cancer in people with diabetes and chronic kidney disease, Nephrol Dial Transplant, vol.27, pp.3337-3344, 2012.

E. Villar, L. Remontet, M. Labeeuw, and R. Ecochard, Effect of Age, Gender, and Diabetes on Excess Death in End-Stage Renal Failure, J Am Soc Nephrol, vol.18, pp.2125-2134, 2007.

A. Kolko, T. Hannedouche, M. Siebert, M. Lassalle, and R. Registre, Initial clinical caracteristics and care indicators for new dialysis patients. REIN-Rapport annuel, 2012.

J. A. Liang, L. M. Sun, J. J. Yeh, F. C. Sung, S. N. Chang et al., The Association Between Malignancy and End-stage Renal Disease in Taiwan, Jpn J Clin Oncol, vol.41, issue.6, pp.752-757, 2011.

Y. Neuzillet, X. Tillou, R. Mathieu, J. A. Long, M. Gigante et al., Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical. Pathologic, and Outcome Features Compared With RCC in the General Population, European Urology, vol.60, pp.366-373, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00577215

M. D. Denton, C. C. Magee, C. Ovuworie, S. Mauiyyedi, M. Pascual et al., Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: A pathologic analysis, Kidney International, vol.61, pp.2201-2209, 2002.

J. H. Stewart, G. Buccianti, L. Agodoa, R. Gellert, M. Mccredie et al., Cancers of the Kidney and Urinary Tract in Patients on Dialysis for End-Stage Renal Disease: Analysis of Data from the United States, J Am Soc Nephrol, vol.14, pp.197-207, 2003.

P. Maisonneuve, L. Agodoa, R. Gellert, J. H. Stewart, G. Buccianti et al., Cancer in patients on dialysis for end-stage renal disease: an international collaborative study, Lancet, vol.354, pp.93-99, 1999.

C. G. Newstead, Cancer risk in patients on dialysis, Lancet, vol.354, pp.90-91, 1999.

J. E. Lee, S. H. Han, B. C. Cho, J. T. Park, T. H. Yoo et al., Cancer in Patients on Chronic Dialysis in Korea, J Korean Med Sci, vol.24, issue.1, pp.95-101, 2009.

S. Vamvakas, U. Bahner, and A. Heidland, Cancer in End-Stage Renal Disease: Potential Factors Involved, Am J Nephrol, vol.18, pp.89-95, 1998.

R. Peces, Malignancy and chronic disease, Saudi J Kidney Transplant, vol.14, issue.1, pp.5-14, 2003.

C. Ayav, J. Deloumeaux, J. Deloumeaux, A. Sarraj, M. Lassalle et al., Survival and mortality for ESRD patients. REIN-Rapport annuel, 2012.

L. Vecchia, C. Negri, E. Franceschi, S. , D. 'avanzo et al., A case-control study of diabetes mellitus and cancer risk, Br J Cancer, vol.70, pp.950-953, 1994.

V. Donadon, M. Balb, P. Casarin, A. Vario, and A. Alberti, Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: Potential role of insulin, World J Gastroenterol, vol.14, issue.37, pp.5695-5700, 2008.

S. S. Coughlin, E. E. Calle, L. R. Teras, J. Petrelli, J. Thun et al., Diabetes Mellitus as a Predictor of Cancer Mortality in a Large Cohort of US Adults, Am J of Epidemiol, vol.159, pp.1160-1167, 2004.

V. M. Macaulay, Insulin-like growth factors and cancer, Br J Cancer, vol.65, pp.311-320, 1992.

B. Arcidiacono, S. Iiritano, A. Nocera, K. Possidente, M. T. Nevolo et al., Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanism, Experimental Diabetes Research, pp.1-12, 2012.

C. Couchoud, B. Stengel, P. Landais, J. C. Aldigier, F. De-cornelissen et al., The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France, Nephrol Dial Transplant, vol.21, pp.411-418, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00452918

P. Iglesias and J. J. Diez, Insulin therapy in renal disease, Diabetes, Obesity and Metabolism, vol.10, pp.811-823, 2008.

G. Biesenbach, A. Raml, B. Schmekal, and G. Eichbauer-sturm, Decreased insulin requirement in relation to GFR in nephropathic Type 1 and insulin-treated Type 2 diabetic patients, Diabetic Medecine, vol.20, pp.642-645, 2003.

C. C. Huang, W. L. Chan, Y. C. Chen, T. J. Chen, S. J. Lin et al., Angiotensin II Receptor Blockers and Risk of Cancer in Patients With Systemic Hypertension, Am J Cardiol, vol.107, pp.1028-1033, 2011.

B. M. Brenner, M. E. Cooper, D. De-zeeuw, W. F. Keane, W. E. Mitch et al., Effetcs of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy, N Engl J Med, vol.345, issue.12, pp.861-869, 2001.

E. J. Lewis, L. G. Hunsicker, W. R. Clarke, T. Berl, M. A. Pohl et al., Renoprotective effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy due to Type 2 Diabetes, N Engl J Med, vol.345, issue.12, pp.851-860, 2001.

G. Verhoest, T. Dolley-hitze, F. Jouan, K. Bensalah, Y. Arlot-bonnemains et al., Renin-angiotensin system and urological cancers, Progrès en urologie, vol.24, pp.73-79, 2014.
URL : https://hal.archives-ouvertes.fr/hal-00916453

X. Yang, C. Ma, W. Y. So, Y. Wang, A. Kong et al., Renin angiotensin system inhibitors may attenuate low LDL cholesterol-related cancer risk in type 2 diabetes

J. J. Caro, M. Salas, A. Ward, and G. Goss, Anemia As an Independent Prognistic Factor for Survival in Patients with Cancer: A systematic, quantitative review, Cancer, vol.91, issue.12, pp.2214-2221, 2001.

Y. S. Lin, F. C. Chiu, J. W. Lin, J. J. Hwang, and J. L. Caffrey, Association of Albuminuria and Cancer Mortality, Cancer Epidemiol Biomarkers Prev, vol.19, issue.11, pp.2950-2957, 2010.

H. L. Hillege, V. Fidler, G. F. Diercks, W. H. Van-gilst, D. Zeeuw et al., Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population, Circulation, vol.106, pp.1777-1782, 2002.

L. Jorgensen, I. Heuch, T. Jenssen, and B. K. Jacobsen, Association of Albuminuria and Cancer Incidence, J Am Soc Nephrology, vol.19, pp.992-998, 2008.

, Atlas de la mortalité par cancer en France métropolitaine (Evolution, 1970.